Koninklijke Philips (NYSE:PHG) Downgraded by Zacks Research to “Hold”

Koninklijke Philips (NYSE:PHG) was downgraded by stock analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

Other analysts have also issued reports about the company. Wall Street Zen lowered Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Sunday, April 5th. Weiss Ratings cut shares of Koninklijke Philips from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday, April 2nd. Sanford C. Bernstein upgraded Koninklijke Philips to a “hold” rating in a report on Wednesday, December 17th. Finally, Royal Bank Of Canada began coverage on Koninklijke Philips in a research report on Wednesday, December 17th. They issued a “sector perform” rating for the company. Four research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Koninklijke Philips Price Performance

Shares of NYSE:PHG opened at $29.09 on Monday. The company has a current ratio of 1.32, a quick ratio of 0.94 and a debt-to-equity ratio of 0.63. Koninklijke Philips has a 1 year low of $21.95 and a 1 year high of $33.44. The business has a fifty day simple moving average of $29.15 and a 200 day simple moving average of $28.42. The firm has a market cap of $28.01 billion, a price-to-earnings ratio of 27.44, a P/E/G ratio of 7.41 and a beta of 0.81.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings data on Tuesday, February 10th. The technology company reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.20. Koninklijke Philips had a return on equity of 13.68% and a net margin of 5.09%.The business had revenue of $5.98 billion during the quarter, compared to analyst estimates of $5.03 billion. As a group, sell-side analysts predict that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Institutional Trading of Koninklijke Philips

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Mondrian Investment Partners LTD acquired a new stake in shares of Koninklijke Philips in the third quarter worth about $215,529,000. Morgan Stanley lifted its position in shares of Koninklijke Philips by 11.0% in the fourth quarter. Morgan Stanley now owns 2,841,880 shares of the technology company’s stock worth $76,958,000 after buying an additional 282,661 shares during the last quarter. Causeway Capital Management LLC lifted its position in shares of Koninklijke Philips by 5.8% in the third quarter. Causeway Capital Management LLC now owns 1,958,112 shares of the technology company’s stock worth $53,378,000 after buying an additional 107,117 shares during the last quarter. Northern Trust Corp lifted its position in shares of Koninklijke Philips by 8.1% in the third quarter. Northern Trust Corp now owns 1,922,551 shares of the technology company’s stock worth $52,409,000 after buying an additional 143,811 shares during the last quarter. Finally, Brandes Investment Partners LP grew its position in shares of Koninklijke Philips by 6.6% in the fourth quarter. Brandes Investment Partners LP now owns 1,725,997 shares of the technology company’s stock valued at $46,740,000 after purchasing an additional 107,356 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.